Jubilant Ingrevia, a company in the Specialty Chemicals industry, reported revenue of ₹1,394 crore and net profit of ₹111 crore for the September 2026 quarter.
Jubilant Ingrevia (NSE: JUBLINGREA) closed at ₹568.25 on 20 Nov 2026, down 21.5% over the past year. Its market capitalisation is ₹9,051 crore and it trades at 25.1 times earnings.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.